New infusion drug aims to keep severe heart failure patients out of hospital
Disease control
Not yet recruiting
This Phase 3 trial tests whether a continuous infusion of alprostadil, a drug that widens blood vessels, can help maintain stability in 600 people with advanced heart failure. Participants receive either the drug or a placebo for 6 months. The main goal is to see if the drug redu…
Phase: PHASE3 • Sponsor: Biopeutics Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC